Agomab Therapeutics NV (AGMB)

$15.61 +0.96 (6.55%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -46.27M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 617,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule in...

Industry: Biotechnology
Sector: Healthcare
Phone: 32 3 318 91 70
Website: agomab.com
Address:
Posthoflei 1/6, Antwerp, Belgium
stockexchange01
stockexchange01 Mar. 30 at 6:11 PM
$AGMB Down nearly 50% since IPO. Yikes! Anything in the works?
0 · Reply
ZdP2
ZdP2 Mar. 30 at 3:15 PM
$AGMB Already down 5$ since I said this last month.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Mar. 26 at 12:45 PM
$VRTX $TVRD $MBOT ONLY 66 WATCHERS IPO RECEIVED U.S PATENT FOR FIBROSIS AN HOUR AGO. GET IN EARLY ----------> $AGMB
1 · Reply
stockexchange01
stockexchange01 Mar. 4 at 8:32 PM
$AGMB 🖕🏿
1 · Reply
stockexchange01
stockexchange01 Feb. 18 at 3:41 PM
$AGMB POS
0 · Reply
ZdP2
ZdP2 Feb. 13 at 12:50 PM
$AGMB Below 5$ soon.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Feb. 12 at 5:24 AM
$AGMB @XPresso here’s an idea … do it yourself ?! JFC
0 · Reply
XPresso
XPresso Feb. 11 at 9:20 PM
$AGMB Does someone has some proper DD?
0 · Reply
TaliscaXi
TaliscaXi Feb. 11 at 4:23 AM
$AGMB I am out …….. 🫠🫠🫠🫠🫠🫠
0 · Reply
TaliscaXi
TaliscaXi Feb. 10 at 7:36 PM
$AGMB 16 resistance
0 · Reply
Latest News on AGMB
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook

Apr 23, 2026, 6:14 PM EDT - 19 days ago

Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook

Agomab receives U.S. patent for AGMB-447

2026-03-26T11:31:39.000Z - 6 weeks ago

Agomab receives U.S. patent for AGMB-447

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Mar 26, 2026, 7:00 AM EDT - 6 weeks ago

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Agomab initiated with an Outperform at Leerink

2026-03-03T11:47:51.000Z - 2 months ago

Agomab initiated with an Outperform at Leerink

Agomab initiated with an Overweight at Morgan Stanley

2026-03-03T10:06:01.000Z - 2 months ago

Agomab initiated with an Overweight at Morgan Stanley

Agomab initiated with an Overweight at JPMorgan

2026-03-03T10:05:11.000Z - 2 months ago

Agomab initiated with an Overweight at JPMorgan

Agomab Announces Closing of Initial Public Offering

Feb 9, 2026, 4:05 PM EST - 3 months ago

Agomab Announces Closing of Initial Public Offering

Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut

Feb 6, 2026, 12:48 PM EST - 3 months ago

Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut

Agomab opens at $14.70, IPO priced at $16.00

2026-02-06T17:40:13.000Z - 3 months ago

Agomab opens at $14.70, IPO priced at $16.00

Agomab indicated to open at $15.50, IPO priced at $16

2026-02-06T15:55:19.000Z - 3 months ago

Agomab indicated to open at $15.50, IPO priced at $16

Agomab Announces Pricing of Initial Public Offering

Feb 5, 2026, 7:24 PM EST - 3 months ago

Agomab Announces Pricing of Initial Public Offering

Agomab Therapeutics files for US IPO

Jan 16, 2026, 4:43 PM EST - 4 months ago

Agomab Therapeutics files for US IPO

AgomAb Therapeutics IPO Registration Document (F-1)

Jan 16, 2026, 4:19 PM EST - 4 months ago

AgomAb Therapeutics IPO Registration Document (F-1)

stockexchange01
stockexchange01 Mar. 30 at 6:11 PM
$AGMB Down nearly 50% since IPO. Yikes! Anything in the works?
0 · Reply
ZdP2
ZdP2 Mar. 30 at 3:15 PM
$AGMB Already down 5$ since I said this last month.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Mar. 26 at 12:45 PM
$VRTX $TVRD $MBOT ONLY 66 WATCHERS IPO RECEIVED U.S PATENT FOR FIBROSIS AN HOUR AGO. GET IN EARLY ----------> $AGMB
1 · Reply
stockexchange01
stockexchange01 Mar. 4 at 8:32 PM
$AGMB 🖕🏿
1 · Reply
stockexchange01
stockexchange01 Feb. 18 at 3:41 PM
$AGMB POS
0 · Reply
ZdP2
ZdP2 Feb. 13 at 12:50 PM
$AGMB Below 5$ soon.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Feb. 12 at 5:24 AM
$AGMB @XPresso here’s an idea … do it yourself ?! JFC
0 · Reply
XPresso
XPresso Feb. 11 at 9:20 PM
$AGMB Does someone has some proper DD?
0 · Reply
TaliscaXi
TaliscaXi Feb. 11 at 4:23 AM
$AGMB I am out …….. 🫠🫠🫠🫠🫠🫠
0 · Reply
TaliscaXi
TaliscaXi Feb. 10 at 7:36 PM
$AGMB 16 resistance
0 · Reply
Makememillionaire
Makememillionaire Feb. 10 at 4:28 PM
$AGMB There is not much selling except for low information Traders. This will move once book runner decides
1 · Reply
KingOfDaytrades
KingOfDaytrades Feb. 10 at 4:05 PM
$AGMB sold at 15.70. Good day trade - could go higher, but I am a DayTrader :)
0 · Reply
WubbyDubbyBubby
WubbyDubbyBubby Feb. 10 at 4:05 PM
$AGMB
0 · Reply
TaliscaXi
TaliscaXi Feb. 10 at 3:43 PM
$AGMB break 16.01 will be explosion
0 · Reply
mrtallman
mrtallman Feb. 10 at 3:36 PM
$AGMB best bio stock since Pfizer. $100
0 · Reply
Blueeyes12
Blueeyes12 Feb. 10 at 3:31 PM
$AGMB
0 · Reply
WubbyDubbyBubby
WubbyDubbyBubby Feb. 10 at 3:30 PM
$AGMB
0 · Reply
TaliscaXi
TaliscaXi Feb. 10 at 3:17 PM
$AGMB ✈️✈️✈️✈️✈️✈️
0 · Reply